Glutamate receptors and schizophrenia

Anis N.A. , Berry S.C. , Burton N.R. , Lodge D. 1983 The dissociative anaesthetics, ketamine and phencydidine, selectively reduce excitation of central neurones by N-methyl-aspartate. British Journal of Pharmacology 79. 565-575

Bakker C.B. , Amini F.B. 1961 Observations on the psychotomimetic effects of Sernyl . Comprehensive Psychiatry 2: 269-280

Bartschat D.K. , Blaustein M.P. 1986 Phencyclidine in low doses selectively blocks a presynaptic voltage-regulated potassium channel in rat brain. Proceedings of National Academy of Science 83: 189-192

Berry S.C. , Dawkins S.L. , Lodge D. 1984 Comparison of sigma-and kappa-opiate receptor ligands as excitatory amino acid antagonists. British Journal of Pharmacology .83: 179-185

Bjerkenstedt L. , Edman G. , Hagenfeldt L. , Sedvall G. , Wiesel F.A. 1985 Plasma ammo acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls British Journal of Psychiatry 147: 276-282

Cheramy A. , Romo R. , Godehu G. , Baruch P. , Glowinski J. 1986 In vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitatory or inhibitory influence of L-glutamate . Neuroscience 19: 1081-1090

Contreras P.C. , DiMaggio D.A. , O'Donohue T.L. 1987 An endogenous ligand for the sigma opioid binding site Synapse 1: 57-61

Crow T.J. 1987 The dopamine hypothesis survives, but there must be a way opened. British Journal of Psychiatry 151: 460-465

Davies J. , Evans R.H. , Jones A.W. , Smith D A S , Watkins J.C. 1982 Differential activation and blockage of excitatory ammo acid receptors in the mammalian and amphibian central neurons system Comparative Biochemistry and physiology 72C: 211-224

Early T.S. , Reiman E.M. , Raichle M.E. , Spitznagel E.L. 1987 Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proceedings of National Academy of Science 84: 561-563

Etienne P. , Baudry M. 1987 Calcium dependent aspects of synaptic plasticity, excitatory amino acid neurotransmission, brain aging and schizophrenia: a unifying hypothesis . Neurobiology of Aging 8: 367-386.

Falkai P. , Bogerts B. 1986 Cell loss in the hippocampus of schizophrenics . European Archives of Psychiatry and Neurological Sciences 236: 154-161

Farde L. , Wiesel F.A. , Hall H. , Halldin C. , Stone-Elander S. , Sedvall G. 1987 No D2 receptor increase in PET study of schizophrenia Archives of General psychiatry 44: 671-672

Frey P. , Berney D. , Herrling P.L. , Mueller W. , Urwyler S. 1988 6, 7-Dichloro 3-hydroxy 2 quinoxaline carboxylic acid is a relatively potent antagonist of NMDA and kainate receptors. Neuroscience Letters (in press).

Globus M Y T , Gmsberg M.D. , Busto R. , Dietrich W.D. , Valdes I. 1987 Substantia nigra lesion protects against ischemic damage in the striatum: correlation between morphological changes and radiolabelled calcium uptake Journal of Cerebral Blood Flow Metabolism 7 S143

Honore T. , Davies S.N. , Drejer J. , Fletcher E.J. , Jacobsen P. , Lodge D. , Nielsen F.E. 1987 Abstracts Society for Neuroscience 17th Annual Meeting New Orleans, Vol 1, p. 383

Huttenlocher P. 1979 Synaptic density in the human frontal cortex: developmental changes and effects of aging. Brain Research 163: 195-205

Johnson J.W. , Ascher P. 1987 Glycine potentiates the NMDA response in cultured mouse brain neurons Nature 325: 529-531

Jones S.M. , Snell L.D. , Johnson K.M. 1987 Inhibition by phencyclidine of excitatory ammo acid-stimulated release of neurotransmitter in the nucleus accumbens Neuropharmacology 26: 173-179

Kerwm R.W. , Patel S. , Meldrum B.S. , Czudeck C. , Reynolds G.P. 1988 Asymmetrical loss of a glutamate receptor subtype in left hippocampus in post-mortem schizophrenic brain. Lancet (i) 583-584

Kim J.S. , Kornhuber H.H. , Schmid-Burgk W. , Holzmuller B. 1980 Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia Neuroscience Letters 20: 379-382

Kleinschmidt A. , Bear M.F. , Singer W. 1987 Blockage of `NMDA' receptors disrupts experience-dependent plasticity of kitten striate cortex. Science 238: 355-358

Knapp A.G. , Dowling J.E. 1987 Dopamine enhances excitatory amino acid-gated conductances in cultured retinal horizontal cells Nature 325: 437-439

Koek W. , Kleer E. , Mudar P.J. , Woods J.D. 1986 Phencyclidine-like catalepsy induced by the excitatory ammo acid antagonist DL-2-amino-5-phosphonovalerate. Behavioural Brain Research 19: 257-259

Koek W. , Woods J.H. , Ornstein P. 1987 A simple and rapid method for assessing similarities among directly observable behavioral effects of drugs: PCP-like effects of 2-amino-5-phosphonovalerate in rats Psychopharmacology 91: 297-304

Kornhuber J. , Fischer E.G. 1982 Glutamic acid diethyl ester induces catalepsy in rats A new model for schizophrenia? Neuroscience Letters 24: 93-96

Luby E.D. , Gottlieb J.S. , Cohen B.C. , Rosenbaum A. , Domino E.F. 1962 Model psychoses and schizophrenia. American Journal of Psychiatry 119: 61-67

Marien M. , Brien J. , Jhamandas K. 1983 Regional release of [3H] dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine and L-glutamic acid Canadian Journal of Physiology and Pharmacology 61: 43-60

Mendelsohn L.G. , Kalra V. , Johnson B.G. , Kerchner G.A. 1985 Sigma opioid receptor; characterization and co-identity with the phencyclidine receptor Journal of Pharmacology and Experimental Therapeutics 233: 597-602

Mitchell P.R. , Doggett N.S. 1980 Modulation of striatal [3H]glutamic acid release by dopaminergic drugs Life Science 26: 2073-2081

Monaghan D.T. , Holets V.R. , Troy D.W. , Cotman C.W. 1983 Anatomical distributions of four pharmacologically distinct 3H-L-glutamate binding sites. Nature 306: 176-179

Monaghan D.T. , Yao D. , Cotman C.W. 1984 Distribution of [3H]-AMPA binding sites in rat brain as determined by quantitative autoradiography Brain Research 324: 160-164

Morris R G M , Anderson E. , Lynch G.S. , Baudry M. 1986 Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 . Nature 319 774-776

Newlin D.B. , Carpenter B. , Golden C.J. 1981 Hemispheric asymmetries in schizophrenia. Biological Psychiatry 16: 561-582

Nishikawa T. , Takashima M. , Toru M. 1983 Increased [3H] kainic acid binding in the prefrontal cortex in schizophrenia Neuroscience Letters 40: 245-250

Patel S. , Meldrum B.S. , Collins J.F. 1986 Distribution of [3H] kainic acid and binding sites in the rat brain: in vivo and in vitro receptor autoradiography . Neuroscience Letters 70: 301-307

Quirion R. , DiMaggio D.A. , French E.D. , Contreras P.C. , Shiloach J. , Pert C.B. , Everist H. , Pert A. , O'Donohue T.L. 1984 Evidence for an endogenous peptide ligand for the phencyclidine receptor Peptides 5: 967-973

Rowlands R.J. , Roberts P.J. 1980 Activation of dopamine receptors inhibits calcium-dependent glutamate release from corticostriatal terminals in vitro. European Journal of Pharmacology 62: 241-242

Seeman P. , Ulpian C. , Bergeron C. , Riederer P. , Jellinger K. , Gabnel E. , Reynolds G.P. , Tourtelotte W.W. 1984 Bimodal distribution of dopamine receptor densities in brains of schizophrenics Science 225: 728-731

Sherman A.D. , Mott J. 1984 Direct effect of neuroleptics on glutamate release Neuropharmacology 23. 1253-1259

Snell L.D. , Johnson K.M. 1985 Antagonism of NMDA-induced transmitter release in the rat striatum by phencyclidine-like drugs and its relationship to turning behavior Journal of Pharmacology and Experimental Therapy 235: 50-57

Sorensen R.G. , Blaustein M.P. 1988 The rat brain phencyclidine (PCP) receptor a putative K + channel Biochemical Pharmacology 37: 511-579

Stone T.W. , Burton N.R. 1988 NMDA receptors and ligands in the vertebrate CNS Progress in Neurobiology 30 333-368

Weinberger D. 1987 Implications of normal brain development for the pathogenesis of schizophenia. Archives of General Psychiatry 44: 660-669

Wong D.F. , Wagner H.N. , Tune L.E. , Dannals R.F. , Pearlson G.D. , Links J.M. , Tamminga C.A. , Broussolle E.P. , Ravert H.T. , Wilson A.A. , Thoung J K T, Malat J. , Williams J.A. , O'Tuama L.A. , Snyder S.H. , Kuhar M.J. , Gjedde A. 1986a Positron emission tomography reveals elevated D 2 dopamine receptors in drug-naive schizophrenics. Science 234: 1558-1563

Wong E H F , Kemp J.A. , Pnestley T. , Knight A.R. , Woodruff G.N. , Iversen L.L. 1986b The anticonvulsant MK 801 is a potent N-methyl-D-aspartate antagonist Proceedings of the National Academy of Sciences USA 83: 7104-7108

Zukin R.S. , Zukin S.R. 1981 Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites Molecular Pharmacology 20: 246-254